Literature DB >> 2081515

The hyperoxaluric syndromes.

T R Wandzilak1, H E Williams.   

Abstract

Oxalate is a major component of renal stones and an important determinant of calcium oxalate solubility in urine. Although the well-defined hyperoxaluric states are relatively uncommon, a significant number of patients with calcium oxalate stones have some degree of hyperoxaluria. For these reasons an understanding of both the causes of hyperoxaluria and methods of controlling oxalate synthesis and excretion is important. This review focuses on methods for the measurement of oxalate, the metabolic pathways of oxalate synthesis, the transport and excretion of oxalate, and the hyperoxaluric syndromes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2081515

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  6 in total

Review 1.  Oxalate transport and calcium oxalate renal stone disease.

Authors:  C F Verkoelen; J C Romijn
Journal:  Urol Res       Date:  1996

2.  Initial manifestation of primary hyperoxaluria type I in adults-- recognition, diagnosis, and management.

Authors:  J J Kuiper
Journal:  West J Med       Date:  1996-01

3.  Prucalopride-associated acute tubular necrosis.

Authors:  Vithika Sivabalasundaram; Flavio Habal; David Cherney
Journal:  World J Clin Cases       Date:  2014-08-16       Impact factor: 1.337

Review 4.  Cell cultures and nephrolithiasis.

Authors:  C F Verkoelen; B G van der Boom; F H Schröder; J C Romijn
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

5.  Gastrointestinal oxalic acid absorption in calcium-treated rats.

Authors:  Makoto Morozumi; Rayhan Zubair Hossain; Ken-ichi Yamakawa; Sanehiro Hokama; Saori Nishijima; Yoshinori Oshiro; Atsushi Uchida; Kimio Sugaya; Yoshihide Ogawa
Journal:  Urol Res       Date:  2006-01-28

6.  Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.

Authors:  Josephine S Gnanandarajah; Juan E Abrahante; Jody P Lulich; Michael P Murtaugh
Journal:  Urol Res       Date:  2012-01-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.